Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide.

Autor:	Lim, I. Vern, Yurttaş, Nurgül Özgür, Ayer, Mesut, Poturoğlu, Şule, Kınacı, Erdem, Özden, İlgin
Předmět:	LIVER transplantation NEUTROPENIA TENOFOVIR ADULTS COVID-19
Zdroj:	Clinical Case Reports; Aug2023, Vol. 11 Issue 8, p1-6, 6p
Abstrakt:	Key Clinical Message: At 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 109/L). Covid resolution and all "conventional" modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafenamide. A step‐by‐step judicious approach to post‐transplant neutropenia is vital. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.